MorphoSys Stock

MorphoSys EV/OCF

Delisted

The EV/OCF (Enterprise Value to Operating Cash Flow) of MorphoSys (MOR.DE) as of Aug 12, 2026 is -9.51. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -7.89 — a change of 20.47% (lower).

EV/OCF

-9.51

YoY

20.47%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of MorphoSys is 2026 -9.51 . EV/OCF (Enterprise Value to Operating Cash Flow) of MorphoSys was 2025 -7.89 . It decreases by 20.47% lower compared to the previous year.
Access this data via the Eulerpool API

MorphoSys Stock analysis

What does MorphoSys do? MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MorphoSys stock

EV/OCF (Enterprise Value to Operating Cash Flow) of MorphoSys is -9.51 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of MorphoSys changed from -7.89 to -9.51, representing a 20.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) MorphoSys since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s MorphoSys with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — MorphoSys

All Key Metrics — MorphoSys